
Meet 2 type 2 diabetes patients on multiple antihyperglycemics but still not meeting the ADA recommended A1c goal of 7%. What are the next best steps?
Meet 2 type 2 diabetes patients on multiple antihyperglycemics but still not meeting the ADA recommended A1c goal of 7%. What are the next best steps?
Three patients with type 2 diabetes in different stages of life and disease all require insulin management for A1c control.
These 3 case studies illustrate the challenges of intensifying treatment in complex T2D patients--and also the options available to individualize that next step.
When intensifying T2DM therapy to reach glycemic goals, newer agents target common comorbidities. Which would you choose in these 3 scenarios?
Published: June 24th 2020 | Updated:
Published: June 29th 2020 | Updated:
Published: July 18th 2019 | Updated:
Published: March 13th 2020 | Updated: